Arcutis Biotherapeutics, Inc.
-
Ticker
ARQT
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Westlake Village, California
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to
…More solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
Arcutis Biotherapeutics, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Report Locked. Arcutis Biotherapeutics, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Arcutis Biotherapeutics, Inc. Sustainability Report, Arcutis Biotherapeutics, Inc. Corporate Social Responsibility Report, Arcutis Biotherapeutics, Inc. CSR Report, Arcutis Biotherapeutics, Inc. Corporate Responsibility, Arcutis Biotherapeutics, Inc. CR Report, Arcutis Biotherapeutics, Inc. Citizenship Report, Arcutis Biotherapeutics, Inc. ESG Report, and Arcutis Biotherapeutics, Inc. Environmental Report online.